Yoshinobu Kanda

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 55

Top Venues

Bone marrow transplantation

International journal of hematology

Hematological oncology

British journal of haematology

Jichi Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jichi Medical University Apr 1o 2007

Japan

Professor :: Division of Hematology

Publications

Shimpei Matsumi, Shun-Ichi Kimura, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Ayumi Gomyo, Yosuke Okada, Yu Akahoshi, Masaharu Tamaki, Machiko Kusuda, Kazuaki Kameda, Hidenori Wada, Aki Tanihara, Miki Sato, Hideki Nakasone, Shinichi Kako, Yoshinobu Kanda
Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation. International journal of hematology (2023)
Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, Atsuto Noguchi, Shuka Aoe, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Kazuki Hyodo, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies. British journal of haematology 200 (6) (2023)
Risa Koresawa-Shimizu, Ritsuro Suzuki, Yasufumi Uehara, Nobuhiro Hiramoto, Masashi Sawa, Takahiro Fukuda, Keisuke Kataoka, Yoshinobu Kanda, Tatsuo Oyake, Yasushi Kubota, Naoyuki Uchida, Shingo Yano, Hikaru Kobayashi, Junji Tanaka, Yoshiko Atsuta, Eisei Kondo
Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry. Bone marrow transplantation (2023)
Shigeo Fuji, Akitoshi Hakoda, Junya Kanda, Takahiro Fukuda, Noriko Doki, Yuta Katayama, Naoyuki Uchida, Yukiyasu Ozawa, Yoshinobu Kanda, Masatsugu Tanaka, Keisuke Kataoka, Takahide Ara, Masashi Sawa, Makoto Onizuka, Yasushi Onishi, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Ayumi Shintani, Satoko Morishima
Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy. Bone marrow transplantation (2023)
Yosuke Okada, Hideki Nakasone, Kazuki Yoshimura, Masaharu Tamaki, Machiko Kusuda, Yuhei Nakamura, Masakatsu Kawamura, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Ayumi Gomyo, Aki Tanihara, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Plasma ubiquitin C-terminal hydrolase-L1 (UCH-L1) level as a blood biomarker of neurological damage after allogeneic hematopoietic cell transplantation. International journal of hematology (2023)
Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, Atsuto Noguchi, Shuka Aoe, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Kazuki Hyodo, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies. British journal of haematology 200 (6) (2023)
Machiko Kusuda, Hideaki Nakasone, Kazuki Yoshimura, Yosuke Okada, Masaharu Tamaki, Akari Matsuoka, Takuto Ishikawa, Tomohiro Meno, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Yukiko Misaki, Ayumi Gomyo, Aki Tanihara, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patients. British journal of haematology (2023)
Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, Atsuto Noguchi, Shuka Aoe, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Kazuki Hyodo, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies. British journal of haematology 200 (6) (2023)
Shigeki Hirabayashi, Tadakazu Kondo, Satoshi Nishiwaki, Shuichi Mizuta, Noriko Doki, Takahiro Fukuda, Naoyuki Uchida, Yukiyasu Ozawa, Yoshinobu Kanda, Ryota Imanaka, Satoshi Takahashi, Jun Ishikawa, Shingo Yano, Hirohisa Nakamae, Tetsuya Eto, Takafumi Kimura, Junji Tanaka, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako
Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph + ALL: A retrospective nationwide study. American journal of hematology (2023)
Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, Atsuto Noguchi, Shuka Aoe, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Kazuki Hyodo, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies. British journal of haematology (2023)
Masamitsu Yanada, Yoshimitsu Shimomura, Shohei Mizuno, Kensuke Matsuda, Tadakazu Kondo, Noriko Doki, Masatsugu Tanaka, Takahiro Fukuda, Takahide Ara, Naoyuki Uchida, Makoto Onizuka, Masashi Sawa, Yukiyasu Ozawa, Nobuhiro Hiramoto, Shuichi Ota, Junya Kanda, Yoshinobu Kanda, Tatsuo Ichinohe, Shinichiro Okamoto, Yoshiko Atsuta, Takaaki Konuma
External validation and extended application of the transplant conditioning intensity score in acute myeloid leukemia. Bone marrow transplantation (2023)
Yoshinobu Kanda, Kensuke Usuki, Mitsuhiro Inagaki, Akiko Ohta, Yoji Ogasawara, Naoshi Obara, Shinichi Kako, Mineo Kurokawa, Naoki Shimada, Takahiro Suzuki, Asahito Hama, Hiroki Yamaguchi, Shinji Nakao, Hirohito Yamazaki
Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia. International journal of hematology (2023)
Takashi Ikeda, Kazuya Sato, Shin-Ichiro Kawaguchi, Junko Izawa, Norihito Takayama, Hiroko Hayakawa, Kento Umino, Kaoru Morita, Kana Matsumoto, Kentaro Ushijima, Yoshinobu Kanda
Forodesine Enhances Immune Responses through Guanosine-Mediated TLR7 Activation while Preventing Graft-versus-Host Disease. Journal of immunology (Baltimore, Md. : 1950) (2023)
Yoshinobu Kanda, Takehiko Mori, Atsushi Narita, Kevin D Wolter, Hiroki Yoshimatsu, Kazuma Nishimura
Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series. International journal of hematology (2023)
Yoshihiro Inamoto, Wataru Takeda, Tsuneaki Hirakawa, Hirotoshi Sakaguchi, Nobuaki Nakano, Naoyuki Uchida, Noriko Doki, Kazuhiro Ikegame, Yuta Katayama, Masashi Sawa, Takuro Kuriyama, Nobuhiro Hiramoto, Shuichi Ota, Yukiyasu Ozawa, Keisuke Kataoka, Yoshinobu Kanda, Moeko Hino, Takafumi Kimura, Yoshiko Atsuta, Takahiro Fukuda, Koji Nagafuji
Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis. American journal of hematology 97 (12) (2022)
Machiko Kusuda, Hideki Nakasone, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Aki Tanihara, Masaharu Tamaki, Kazuaki Kameda, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Very early death within 30 days after diagnosis in patients with acute myeloid leukemia. International journal of hematology (2022)
Yu Akahoshi, Hideki Nakasone, Machiko Kusuda, Kazuaki Kameda, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Aki Tanihara, Masaharu Tamaki, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT. International journal of hematology 115 (5) (2022)
Jin Hayakawa, Hideki Nakasone, Daisuke Minakata, Shin-Ichiro Fujiwara, Ayumi Gomyo, Yu Akahoshi, Yusuke Komiya, Naonori Harada, Tomotaka Ugai, Kazuaki Kameda, Hidenori Wada, Yuko Ishihara, Koji Kawamura, Kana Sakamoto, Miki Sato, Kiriko Terasako-Saito, Misato Kikuchi, Shun-Ichi Kimura, Junya Kanda, Shinichi Kako, Yoshinobu Kanda
Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. International journal of hematology 116 (2) (2022)
Yoshinobu Kanda, Takehiko Mori, Atsushi Narita, Kevin D Wolter, Hiroki Yoshimatsu, Kazuma Nishimura
Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series. International journal of hematology (2022)
Shun-Ichi Kimura, Hiroaki Shimizu, Takuya Miyazaki, Masatoshi Sakurai, Susumu Tanoue, Kensuke Kayamori, Chikako Ohwada, Kazuki Yoshimura, Hideaki Nakasone, Takuma Ohashi, Katsuhiro Shono, Takayoshi Tachibana, Kaoru Hatano, Keigo Okada, Yuta Kimura, Sachiko Seo, Noriko Doki, Masatsugu Tanaka, Yoshihiro Hatta, Satoshi Takahashi, Yoshinobu Kanda, null null
Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2022)
Takaaki Konuma, Kaito Harada, Tadakazu Kondo, Masayoshi Masuko, Naoyuki Uchida, Shingo Yano, Toshiro Kawakita, Makoto Onizuka, Shuichi Ota, Emiko Sakaida, Shigesaburo Miyakoshi, Yukiyasu Ozawa, Yutaka Imamura, Takafumi Kimura, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Masamitsu Yanada, null null
Salvage single-unit unrelated cord blood transplantation for graft failure following initial allogeneic transplantation in adult acute myeloid leukemia: trends in outcomes over the past 20 years. Bone marrow transplantation 57 (12) (2022)
Kaoru Hatano, Shin-Ichiro Fujiwara, Kento Umino, Takashi Ikeda, Hirofumi Nakano, Kiyomi Mashima, Shin-Ichiro Kawaguchi, Shoko Ito, Yumiko Toda, Takashi Nagayama, Daisuke Minakata, Ryoko Yamasaki, Kaoru Morita, Chihiro Yamamoto, Masahiro Ashizawa, Kazuya Sato, Masuzu Ueda, Ken Ohmine, Yoshinobu Kanda
Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma. Annals of hematology 101 (6) (2022)
Takaaki Konuma, Junya Kanda, Naoyuki Uchida, Akihiko Nishijima, Masatsugu Tanaka, Yukiyasu Ozawa, Masashi Sawa, Makoto Onizuka, Shuichi Ota, Yumiko Maruyama, Yoshinobu Kanda, Toshiro Kawakita, Takahide Ara, Tetsuya Eto, Hirohisa Nakamae, Takafumi Kimura, Takahiro Fukuda, Yoshiko Atsuta, null null
Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation. Hematological oncology (2022)
Yoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, Tomotaka Sobue, Shuhei Kurosawa, Kazuteru Ohashi, Yuta Katayama, Yukiyasu Ozawa, Ken-Ichi Matsuoka, Takashi Tanaka, Shinichi Kako, Masashi Sawa, Yoshinobu Kanda, Hirohisa Nakamae, Hideyuki Nakazawa, Yasunori Ueda, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Ken Ishiyama
Identifying the optimal conditioning intensity for stem cell transplantation in patients with myelodysplastic syndrome: a machine learning analysis. Bone marrow transplantation (2022)
Takaaki Konuma, Yoshimitsu Shimomura, Ken Ishiyama, Takahide Ara, Hirohisa Nakamae, Nobuhiro Hiramoto, Tetsuya Eto, Yumiko Maruyama, Koji Nagafuji, Jun Ishikawa, Naoyuki Uchida, Masatsugu Tanaka, Makoto Onizuka, Yasunori Ueda, Naoyuki Anzai, Takafumi Kimura, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta
Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation for myelodysplastic syndrome: A retrospective study from the Adult Myelodysplastic Syndrome Working Group of the Japanese Society for Transplantation and Cellular Therapy (JSTCT). American journal of hematology 97 (12) (2022)
Shigeo Fuji, Tsuneaki Hirakawa, Kuniko Takano, Kazuteru Ohashi, Masashi Sawa, Yoshinobu Kanda, Naoyuki Uchida, Takahide Ara, Toshihiro Miyamoto, Tetsuya Eto, Ken-Ichi Matsuoka, Toshiro Kawakita, Yukiyasu Ozawa, Yuta Katayama, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Hideki Nakasone
Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group. Bone marrow transplantation 57 (3) (2022)
Masaharu Tamaki, Shimpei Matsumi, Hideaki Nakasone, Yuhei Nakamura, Masakatsu Kawamura, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Ayumi Gomyo, Aki Tanihara, Yosuke Okada, Machiko Kusuda, Kazuaki Kameda, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation 57 (9) (2022)
Yosuke Okada, Katsuto Takenaka, Makoto Murata, Yutaka Shimazu, Takayoshi Tachibana, Yukiyasu Ozawa, Naoyuki Uchida, Toshio Wakayama, Kazuteru Ohashi, Yasuhiro Sugio, Masatsugu Tanaka, Masayoshi Masuko, Hikaru Kobayashi, Kazuko Ino, Jun Ishikawa, Hirohisa Nakamae, Ken-Ichi Matsuoka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Tokiko Nagamura-Inoue
Prognostic impact of complex karyotype on post-transplant outcomes of myelofibrosis. Hematological oncology (2022)
Yoshiko Atsuta, Junichi Sugita, Hirohisa Nakamae, Yumiko Maruyama, Ken Ishiyama, Souichi Shiratori, Takahiro Fukuda, Mio Kurata, Naoki Shingai, Yukiyasu Ozawa, Masayoshi Masuko, Koji Nagafuji, Satoru Takada, Shinichi Kako, Yoshinobu Kanda, Junya Kanda, Tatsuo Ichinohe, Takanori Teshima
Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation. Bone marrow transplantation 57 (12) (2022)
Shohei Mizuno, Akiyoshi Takami, Hiroyuki Takamatsu, Ichiro Hanamura, Yutaka Shimazu, Akira Hangaishi, Nobuhiro Tsukada, Shinichi Kako, Taku Kikuchi, Shuichi Ota, Hiroaki Shimizu, Shinsuke Iida, Satoshi Yoshioka, Masashi Sawa, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Koji Kawamura
Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents. Bone marrow transplantation 57 (5) (2022)
Ryu Yanagisawa, Masaharu Tamaki, Reo Tanoshima, Yukiko Misaki, Naoyuki Uchida, Satoshi Koi, Takashi Tanaka, Yukiyasu Ozawa, Yayoi Matsuo, Masatsugu Tanaka, Kazuhiro Ikegame, Yuta Katayama, Ken-Ichi Matsuoka, Takahide Ara, Yoshinobu Kanda, Kimikazu Matsumoto, Takahiro Fukuda, Yoshiko Atsuta, Motohiro Kato, Hideaki Nakasone
Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group. Hematological oncology (2022)
Yosuke Okada, Hideaki Nakasone, Yuhei Nakamura, Masakatsu Kawamura, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Toshikuni Kawamura, Yu Akahoshi, Machiko Kusuda, Kazuaki Kameda, Aki Tanihara, Masaharu Tamaki, Shun-Ichi Kimura, Shinichi Kobayashi, Shinichi Kako, Fumihiko Kimura, Yoshinobu Kanda
Prognostic impact of chromosomal changes at relapse after allogeneic hematopoietic cell transplantation for acute myeloid leukemia or myelodysplastic syndrome. Bone marrow transplantation 57 (5) (2022)
Mari Morita-Fujita, Yasuyuki Arai, Tadakazu Kondo, Kaito Harada, Naoyuki Uchida, Takashi Toya, Yukiyasu Ozawa, Takahiro Fukuda, Shuichi Ota, Makoto Onizuka, Yoshinobu Kanda, Yumiko Maruyama, Satoru Takada, Toshiro Kawakita, Takahide Ara, Tatsuo Ichinohe, Takafumi Kimura, Yoshiko Atsuta, Shinichi Kako
Adult patients with Ph+ ALL benefit from conditioning regimen of medium-dose VP16 plus CY/TBI. Hematological oncology (2022)
Junko Takeshita, Shun-Ichi Kimura, Hideaki Nakasone, Shunto Kawamura, Yuhei Nakamura, Masakatsu Kawamura, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Masaharu Tamaki, Yu Akahoshi, Machiko Kusuda, Kazuaki Kameda, Hidenori Wada, Hidenori Wada, Shinichi Kako, Yoshinobu Kanda
Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non-relapse mortality after allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society 23 (5) (2021)
Yoshimitsu Shimomura, Masahiko Hara, Shigeki Hirabayashi, Tadakazu Kondo, Shohei Mizuno, Naoyuki Uchida, Junichi Mukae, Toshiro Kawakita, Takahiro Fukuda, Yoshinobu Kanda, Shuichi Ota, Yukiyasu Ozawa, Tetsuya Eto, Yumiko Maruyama, Masatsugu Tanaka, Nobuaki Nakano, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada
Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status. Bone marrow transplantation 56 (9) (2021)
Kazuki Yoshimura, Shun-Ichi Kimura, Masakatsu Kawamura, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Ayumi Gomyo, Shimpei Matsumi, Yu Akahoshi, Masaharu Tamaki, Machiko Kusuda, Kazuaki Kameda, Hidenori Wada, Koji Kawamura, Miki Sato, Kiriko Terasako-Saito, Aki Tanihara, Hideki Nakasone, Shinichi Kako, Yoshinobu Kanda
Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors. International journal of hematology 114 (6) (2021)
Takaaki Konuma, Tadakazu Kondo, Masayoshi Masuko, Hiroaki Shimizu, Souichi Shiratori, Takahiro Fukuda, Jun Kato, Masashi Sawa, Yukiyasu Ozawa, Shuichi Ota, Naoyuki Uchida, Yoshinobu Kanda, Shinichi Kako, Shin Fujisawa, Kentaro Fukushima, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada, null null
Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission. Bone marrow transplantation 56 (11) (2021)
Hisayuki Yokoyama, Junya Kanda, Yuta Kawahara, Naoyuki Uchida, Masatsugu Tanaka, Satoshi Takahashi, Makoto Onizuka, Yuma Noguchi, Yukiyasu Ozawa, Yuna Katsuoka, Shuichi Ota, Takanori Ohta, Takafumi Kimura, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Hideaki Nakasone, Satoko Morishima
Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation. Bone marrow transplantation 56 (6) (2021)
Hideaki Nakasone, Shinichi Kako, Takehiko Mori, Satoshi Takahashi, Makoto Onizuka, Shin-Ichiro Fujiwara, Toru Sakura, Emiko Sakaida, Akira Yokota, Nobuyuki Aotsuka, Maki Hagihara, Nobuhiro Tsukada, Yoshihiro Hatta, Kensuke Usuki, Reiko Watanabe, Moritaka Gotoh, Shin Fujisawa, Shingo Yano, Heiwa Kanamori, Shinichiro Okamoto, Yoshinobu Kanda
Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia. Bone marrow transplantation 56 (6) (2021)
Yoshitaka Inoue, Keiji Okinaka, Shigeo Fuji, Yoshihiro Inamoto, Naoyuki Uchida, Takashi Toya, Kazuhiro Ikegame, Tetsuya Eto, Yukiyasu Ozawa, Koji Iwato, Yoshinobu Kanda, Yoshiko Atsuta, Masao Ogata, Takahiro Fukuda, null null
Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study. Bone marrow transplantation 56 (9) (2021)
Masamitsu Yanada, Shuichi Ota, Junichi Mukae, Miho Nara, Shinichi Kako, Akinori Nishikawa, Naoyuki Uchida, Masashi Sawa, Nobuaki Nakano, Makoto Onizuka, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shingo Yano
Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis. Bone marrow transplantation (2021)
Masamitsu Yanada, Naoyuki Uchida, Tatsuo Ichinohe, Takahiro Fukuda, Junya Kanda, Yoshinobu Kanda, Yoshiko Atsuta, Hideaki Nakasone
Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation. Bone marrow transplantation 56 (7) (2021)
Sachiko Seo, Yoshiaki Usui, Keitaro Matsuo, Yoshiko Atsuta, Aiko Igarashi, Takahiro Fukuda, Yukiyasu Ozawa, Yuta Katayama, Shuro Yoshida, Naoyuki Uchida, Tadakazu Kondo, Shinichi Kako, Nobuhiro Tsukada, Shunichi Kato, Makoto Onizuka, Tatsuo Ichinohe, Fumihiko Kimura, Yoshinobu Kanda, Koichi Miyamura, Junya Kanda, null null
Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation. Bone marrow transplantation 56 (10) (2021)
Yu Akahoshi, Yasuyuki Arai, Satoshi Nishiwaki, Takayoshi Tachibana, Akihito Shinohara, Noriko Doki, Naoyuki Uchida, Masatsugu Tanaka, Yoshinobu Kanda, Souichi Shiratori, Yukiyasu Ozawa, Katsuhiro Shono, Yuta Katayama, Junji Tanaka, Takahiro Fukuda, Yoshiko Atsuta, Shinichi Kako
Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCT. Bone marrow transplantation 56 (11) (2021)
Hideaki Nakasone, Machiko Kusuda, Kiriko Terasako-Saito, Koji Kawamura, Yu Akahoshi, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Kazuki Yoshimura, Yukiko Misaki, Ayumi Gomyo, Kazuaki Kameda, Masaharu Tamaki, Aki Tanihara, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation. Communications biology 4 (1) (2021)
Shinichi Kobayashi, Yoshinobu Kanda, Takaaki Konuma, Yoshihiro Inamoto, Kimikazu Matsumoto, Naoyuki Uchida, Kazuhiro Ikegame, Toshihiro Miyamoto, Noriko Doki, Hirohisa Nakamae, Yuta Katayama, Satoshi Takahashi, Souichi Shiratori, Shoji Saito, Toshiro Kawakita, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Fumihiko Kimura
Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation. Bone marrow transplantation (2021)
Shuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, Yuho Najima, Takeshi Kobayashi, Yukiyasu Ozawa, Yoshinobu Kanda, Shinichi Kako, Toshiro Kawakita, Ken-Ichi Matsuoka, Yumiko Maruyama, Shuichi Ota, Hideyuki Nakazawa, Kazunori Imada, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Jun Aoki
Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis. Bone marrow transplantation 56 (12) (2021)
Shinichiro Kawaguchi, Shin-Ichiro Fujiwara, Rui Murahashi, Hirotomo Nakashima, Sae Matsuoka, Takashi Ikeda, Yumiko Toda, Shoko Ito, Tetsuaki Ban, Takashi Nagayama, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Yoshinobu Kanda
Risk factors for high-dose methotrexate-induced nephrotoxicity. International journal of hematology 114 (1) (2021)
Masamitsu Yanada, Takaaki Konuma, Satoshi Yamasaki, Tadakazu Kondo, Takahiro Fukuda, Naoki Shingai, Masashi Sawa, Yukiyasu Ozawa, Masatsugu Tanaka, Naoyuki Uchida, Hirohisa Nakamae, Yuta Katayama, Ken-Ichi Matsuoka, Takafumi Kimura, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shingo Yano
Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes. Bone marrow transplantation 56 (5) (2020)
Shoko Ito, Shin-Ichiro Fujiwara, Rui Murahashi, Hirotomo Nakashima, Sae Matsuoka, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Tetsuaki Ban, Takashi Nagayama, Kento Umino, Daisuke Minakata, Kaoru Morita, Hirofumi Nakano, Ryoko Yamasaki, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Yoshinobu Kanda
Clinical association between thyroid disease and immune thrombocytopenia. Annals of hematology 100 (2) (2020)
Takashi Nagayama, Masahiro Ashizawa, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Shin-Ichi Ochi, Kiyomi Mashima, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Yasufumi Kawasaki, Chihiro Yamamoto, Shin-Ichiro Fujiwara, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda
Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma. Annals of hematology 99 (12) (2020)
Kaoru Morita, Shin-Ichiro Fujiwara, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Yoshinobu Kanda
Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease. Bone marrow transplantation 56 (4) (2020)
Takashi Ikeda, Shin-Ichiro Fujiwara, HIrotomo Nakajima, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Shinichi Ochi, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Yasufumi Kawasaki, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda
Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study. International journal of hematology 112 (3) (2020)
Ayumi Fujimoto, Nobuhiro Hiramoto, Satoshi Yamasaki, Yoshihiro Inamoto, Masao Ogata, Yasuhiro Sugio, Takahiro Fukuda, Naoyuki Uchida, Kazuhiro Ikegame, Ken-Ichi Matsuoka, Souichi Shiratori, Tadakazu Kondo, Toshihiro Miyamoto, Tetsuya Eto, Tatsuo Ichinohe, Yoshinobu Kanda, Yoshiko Atsuta, Ritsuro Suzuki, null null
Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab. Hematological oncology 38 (2) (2020)
Takaaki Konuma, Yoshimitsu Shimomura, Yukiyasu Ozawa, Yasunori Ueda, Naoyuki Uchida, Makoto Onizuka, Megumi Akiyama, Takehiko Mori, Hirohisa Nakamae, Yuju Ohno, Souichi Shiratori, Yasushi Onishi, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Ken Ishiyama, null null
Induction chemotherapy followed by allogeneic HCT versus upfront allogeneic HCT for advanced myelodysplastic syndrome: A propensity score matched analysis. Hematological oncology 37 (1) (2018)

Yoshinobu Kanda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yoshinobu Kanda